Published in Protein Expr Purif on November 05, 2008
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci U S A (2013) 0.90
Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes. J Biol Chem (2016) 0.75
E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell (2006) 2.50
A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol (2003) 1.82
Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol (2007) 1.70
The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol Cell (2007) 1.56
Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol (2009) 1.47
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene (2002) 1.11
Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks. Biochem Soc Trans (2010) 1.02
Proteasome inhibitors: Dozens of molecules and still counting. Biochimie (2010) 1.01
Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells (2009) 1.01
Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene (2003) 1.00
Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuro Oncol (2010) 0.99
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One (2010) 0.94
Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway. J Virol (2002) 0.94
JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis. Mol Cell Biol (2008) 0.93
Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5. BMC Biochem (2005) 0.91
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking. Mol Biol Cell (2008) 0.91
βTrCP-dependent degradation of CDC25B phosphatase at the metaphase-anaphase transition is a pre-requisite for correct mitotic exit. Cell Cycle (2010) 0.87
A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res (2004) 0.83
Regulation of the 26S proteasome activities by peptides mimicking cleavage products. Biochem Biophys Res Commun (2002) 0.83
Unusual early-onset Huntingtons disease. J Child Neurol (2003) 0.79
SUMO2/3 modification of cyclin E contributes to the control of replication origin firing. Nat Commun (2013) 0.78
LIM-only protein FHL3 interacts with CDC25B2 phosphatase. Exp Cell Res (2003) 0.78
Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting. BMC Biochem (2007) 0.78
HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications. Biol Cell (2012) 0.77
Kizuna is a novel mitotic substrate for CDC25B phosphatase. Cell Cycle (2014) 0.75
[Death-tag]. Med Sci (Paris) (2004) 0.75